What will be the leading cause of rejection in pig kidney transplants in 2025?
Hyperacute rejection • 25%
Acute rejection • 25%
Chronic rejection • 25%
Infection-related • 25%
Medical studies and reports published in scientific journals
Alabama Woman Receives Third Genetically Modified Pig Kidney Transplant at NYU Langone Health on November 25, 2024, Ends Dialysis
Dec 17, 2024, 04:37 PM
Towana Looney, a 53-year-old woman from Alabama, has become the third person to receive a genetically modified pig kidney transplant. The procedure, which took place at NYU Langone Health on November 25, 2024, marks a significant advancement in xenotransplantation. Looney, who had been on dialysis for eight years due to kidney failure following a pregnancy complication, is recovering well and no longer requires dialysis. This transplant is the latest in efforts to address the chronic shortage of human organs available for transplant, with more than 100,000 people currently on the U.S. transplant list, most needing kidneys. The pig kidney used in Looney's transplant was provided by Revivicor and featured 10 genetic modifications to enhance compatibility with human recipients and reduce the risk of rejection. Looney's successful transplant is seen as a promising step toward future clinical trials, which are expected to begin next year.
View original story
Rejection • 25%
No major complication • 25%
Organ failure • 25%
Infection • 25%
Ethical concerns • 25%
Other challenges • 25%
Rejection issues • 25%
Infection complications • 25%
Supply chain issues • 25%
Infection risk • 25%
Immune rejection • 25%
Ethical concerns • 25%
1 to 6 months • 25%
More than 12 months • 25%
6 to 12 months • 25%
Less than 1 month • 25%
Other significant advancement • 25%
Improved gene editing techniques • 25%
New animal species used • 25%
Breakthrough in immunosuppressive drugs • 25%
Liver • 25%
Other • 25%
Kidney • 25%
Heart • 25%
Other • 25%
Animal rights • 25%
Human safety • 25%
Religious concerns • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
1-3 • 25%
10 or more • 25%
7-9 • 25%
4-6 • 25%